SWOT Analysis for Aligos Therapeutics Inc - Strengths

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Significant (over 30%) distance from 52 week high

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

Top Gainers

Stock with Low PE (PE < = 10)

Biggest Price Gainers from Open

Stocks with Quarter Change % less than Industry

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Declining profits every quarter for the past 2 quarters

RSI indicating price weakness

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Institutions decreased their shareholding last quarter